Increased levels of lysosomal cysteinyl cathepsins in human varicose veins: A histology study
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Summary: Varicose veins are a major chronic venous disease characterised by extensive remodelling of the extracellular matrix architecture in the vascular wall. Although matrix metalloproteinases have been implicated in these pathologic events, little is known about the functional relevance of other protease family members. Here, we studied the distribution of lysosomal cysteine proteases, cathepsins B, L, K, and S, and their endogenous inhibitor, cystatin C, in long saphenous vein specimens from nine normal donors and 18 patients with varicose veins (VVs). Immunohistochemical analysis demonstrated increased levels of cathepsins L, K, B, and S and reduced levels of cystatin C in VVs. This imbalance between cysteinyl cathepsins and cystatin C may favour VV remodelling. To investigate the inflammatory mechanism of their expression, we examined a detailed inflammatory cell profile in VVs, including macrophages, T lymphocytes, and mast cells. Increased numbers of CD3-positive T cells and tryptase-positive mast cells were found in VVs, and enhanced levels of cysteinyl cathepsins were detected from lesion CD3-positive T cells, chymase-positive mast cells, endothelial cells, and smooth-muscle cells. Elevated cathepsins, and their co-localisation to infiltrated inflammatory cells and to vascular cells, suggest that these proteases participate in extracellular matrix degradation in response to inflammation during VV pathogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growing evidence indicates that cystatin C plays a direct role in various immunological disorders, with its encoding gene being regulated by inflammatory mediators like cytokines in situations of inflammation or infection (16).”
From Investigation of serum cystatin C levels and their diagnostic value in combination with inflammatory ratios in patients with bipolar disorder (2025) · doi:10.3389/fpsyt.2025.1525091 · cites this paper as [16]
Citations
Cites
Inflammatory cytokines in vascular dysfunction and vascular disease
Sprague, A. H., & Khalil, R. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.029 · Cited by 1,352 · cited 11×
“Inflammatory cell infiltration into the vascular wall is an important feature of VVs, and its central roles are broadly evident in vascular diseases (23-27).”
BackgroundInfluentialLiu, J., Divoux, A., Sun, J., Zhang, J., Clément, K., Glickman, J. N., Sukhova, G. K., Wolters, P. J., Du, J., Gorgun, C. Z., et al. (2009) · Nature Medicine · doi:10.1038/nm.1994 · Cited by 796 · cited 1×
“0 (22), and the data were presented as a ratio of cell marker–positive areas from the tissues.”
BackgroundSelf-citationSukhova, G. K., Shi, G. P., Simon, D. I., Chapman, H. A., & Libby, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci181 · Cited by 665 · cited 2×
“These proteases may mediate SMC migration to the intima and free sufficient space in the media for inflammatory infiltrators, as we have described in human atherosclerotic lesions (39).”
BackgroundResultSelf-citationChanging concepts of atherogenesis
Libby, P. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00654.x · Cited by 626 · cited 1×
“Normal vascular tissues possess strictly regulated ECM components, whereas focal tissue damage and ECM remodelling occur in vascular disorders, including aortic aneurysm (35), atherosclerosis (36), and VVs (2, 5-10).”
BackgroundCystatin C deficiency in human atherosclerosis and aortic aneurysms
Shi, G.-P., Sukhova, G. K., Grubb, A., Ducharme, A., Rhode, L. H., Lee, R. T., Ridker, P. M., Libby, P., & Chapman, H. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7709 · Cited by 455 · cited 4×
“For example, Cyst C expression is reduced in atheroma (21), abdominal aortic aneurysms (21) and VVs (▶ Figure 3), but its expression remains almost unchanged in balloon-injured carotid arteries (40) and in myocardium of hypertensive heart failure (41).”
BackgroundSelf-citationLysosomal Cysteine Proteases in Atherosclerosis
Liu, J., Sukhova, G. K., Sun, J.-S., Xu, W.-H., Libby, P., & Shi, G.-P. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000134530.27208.41 · Cited by 393 · cited 16×
“In AAA and atherosclerosis lesions, various inflam- matory cells, including monocytes/macrophages, T cells, and MCs, participate in vascular ECM remodelling by releasing inflammatory cytokines to regulate vascular cell cathepsin expression or by directly releasing cathepsins (11, 18, 24).”
BackgroundResultSelf-citationDeficiency of cathepsin S reduces atherosclerosis in LDL receptor–deficient mice
Sukhova, G. K., Zhang, Y., Pan, J.-H., Wada, Y., Yamamoto, T., Naito, M., Kodama, T., Tsimikas, S., Witztum, J. L., Lu, M. L., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14915 · Cited by 372 · cited 4×
“Cathepsin activities in elastin and collagen degradation (16, 17, 42-44), SMC apoptosis (42, 44) and migration (17), angiogenesis (42, 43), macrophage and T-cell transendothelium migration (16, 17, 42, 43), and T-cell proliferation (42-44) from aortic walls may also apply to venous walls - a hypothesis that was not te…”
BackgroundSelf-citationCathepsin cysteine proteases in cardiovascular disease
Lutgens, S. P. M., Cleutjens, K. B. J. M., Daemen, M. J. A. P., & Heeneman, S. (2007) · The FASEB Journal · doi:10.1096/fj.06-7924com · Cited by 351 · cited 12×
“In AAA and atherosclerosis lesions, various inflam- matory cells, including monocytes/macrophages, T cells, and MCs, participate in vascular ECM remodelling by releasing inflammatory cytokines to regulate vascular cell cathepsin expression or by directly releasing cathepsins (11, 18, 24).”
BackgroundInfluentialSaarinen, J., Kalkkinen, N., Welgus, H. G., & Kovanen, P. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32427-4 · Cited by 315 · cited 11×
“Therefore, although a counterbalance between MMPs and TIMPs may affect vein structural integrity (5), other families of proteolytic enzymes may also participate in VV development.”
BackgroundInfluentialDeficiency of cathepsin S reduces atherosclerosis in LDL receptor–deficient mice
Sukhova, G. K., Zhang, Y., Pan, J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314915 · Cited by 314
Self-citationAikawa, E., Aikawa, M., Libby, P., Figueiredo, J.-L., Rusanescu, G., Iwamoto, Y., Fukuda, D., Kohler, R. H., Shi, G.-P., Jaffer, F. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.827972 · Cited by 310 · cited 2×
“Among all tested cysteine proteases, cathepsins (Cat) S, L, K and their endogenous inhibitor, cystatin C (Cyst C), have been shown to participate directly in these arterial diseases in experimental animals (11-21).”
BackgroundSelf-citationPathogenesis of primary varicose veins
Lim, C. S., & Davies, A. H. (2009) · British Journal of Surgery · doi:10.1002/bjs.6798 · Cited by 294
Where does venous reflux start?
Labropoulos, N., Giannoukas, A. D., Delis, K., Mansour, M. A., Kang, S. S., Nicolaides, A. N., Lumley, J., & Baker, W. H. (1997) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(97)70084-3 · Cited by 281 · cited 1×
“But several observations challenged this theory: Normal valves appear frequently in varicose segments (32), valvular incompetence is often followed by dilation (32), and venous dilatation occurs usually in the distal but not at the proximal to the valve (33).”
BackgroundJaffer, F. A., Kim, D.-E., Quinti, L., Tung, C.-H., Aikawa, E., Pande, A. N., Kohler, R. H., Shi, G.-P., Libby, P., & Weissleder, R. (2007) · Circulation · doi:10.1161/circulationaha.106.660340 · Cited by 267
Self-citationActivation of Matrix-Degrading Metalloproteinases by Mast Cell Proteases in Atherosclerotic Plaques
Johnson, J. L., Jackson, C. L., Angelini, G. D., & George, S. J. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.11.1707 · Cited by 265 · cited 1×
“Indeed, studies have reported that chymase activates cathepsins in AAA (45), and that tryptase activates MMPs in atheroma and in the capillary tubular network (52, 53).”
BackgroundMechanisms of varicose vein formation: valve dysfunction and wall dilation
Raffetto, J. D., & Khalil, R. A. (2008) · Phlebology: The Journal of Venous Disease · doi:10.1258/phleb.2007.007027 · Cited by 245 · cited 1×
“A widely accepted theory is that changes in the venous wall architecture precede valvular incompetence and the development of overt varicosities (34).”
BackgroundLiu, J., Sukhova, G. K., Yang, J.-T., Sun, J., Ma, L., Ren, A., Xu, W.-H., Fu, H., Dolganov, G. M., Hu, C., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.05.012 · Cited by 222 · cited 21×
“Increased levels of cysteinyl cathepsins in ECs from VVs (▶ Figure 6 D and Suppl.”
BackgroundMethodResultSelf-citationSaunders, W. B., Bayless, K. J., & Davis, G. E. (2005) · Journal of Cell Science · doi:10.1242/jcs.02360 · Cited by 215 · cited 1×
“Indeed, studies have reported that chymase activates cathepsins in AAA (45), and that tryptase activates MMPs in atheroma and in the capillary tubular network (52, 53).”
BackgroundZhang, J., Alcaide, P., Liu, L., Sun, J., He, A., Luscinskas, F. W., & Shi, G.-P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014525 · Cited by 199 · cited 1×
“After exposure to inflammatory molecules from circulating inflammatory cells, ECs express enhanced levels of cell surface adhesion molecules to trap inflammatory cells (54).”
BackgroundSelf-citationPrimary chronic venous disorders
Meissner, M. H., Gloviczki, P., Bergan, J., Kistner, R. L., Morrison, N., Pannier, F., Pappas, P. J., Rabe, E., Raju, S., & Villavicencio, J. L. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.08.038 · Cited by 195 · cited 1×
“As a major syndrome of chronic venous disease, varicose veins (VVs) — affecting approximately one-third of the Western population and about 15% of the Chinese population at 45 years of age or older —are clinically characterised by abnormal dilatation, tortuosity, and elongation of the veins (1).”
BackgroundExtracellular Proteases in Atherosclerosis and Restenosis
Garcia-Touchard, A., Henry, T. D., Sangiorgi, G., Spagnoli, L. G., Mauriello, A., Conover, C., & Schwartz, R. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000164311.48592.da · Cited by 157 · cited 12×
“In AAA and atherosclerosis lesions, various inflam- matory cells, including monocytes/macrophages, T cells, and MCs, participate in vascular ECM remodelling by releasing inflammatory cytokines to regulate vascular cell cathepsin expression or by directly releasing cathepsins (11, 18, 24).”
BackgroundInfluentialCritical Role of Mast Cell Chymase in Mouse Abdominal Aortic Aneurysm Formation
Sun, J., Zhang, J., Lindholt, J. S., Sukhova, G. K., Liu, J., He, A., Åbrink, M., Pejler, G., Stevens, R. L., Thompson, R. W., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.849679 · Cited by 152 · cited 13×
“Several studies have demonstrated that MCs and their specific proteases, tryptases and chymases, activate cathepsins (24, 45) and MMPs (48); convert angiotensin-I to angiotensin-II (24); degrade ECM fibronectin (49, 50); and induce SMC detachment and apoptosis (49).”
BackgroundResultSelf-citationProteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator
Keski‐Oja, J., Lohi, J., Tuuttila, A., Tryggvason, K., & VARTIO, T. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90101-d · Cited by 150 · cited 1×
“Several studies have demonstrated that MCs and their specific proteases, tryptases and chymases, activate cathepsins (24, 45) and MMPs (48); convert angiotensin-I to angiotensin-II (24); degrade ECM fibronectin (49, 50); and induce SMC detachment and apoptosis (49).”
BackgroundSmooth muscle cell modulation and cytokine overproduction in varicose veins. Anin situ study
Badier-Commander, C., Couvelard, A., Henin, D., Verbeuren, T., Michel, J.-B., & Jacob, M.-P. (2001) · The Journal of Pathology · doi:10.1002/path.819 · Cited by 149 · cited 4×
“Normal vascular tissues possess strictly regulated ECM components, whereas focal tissue damage and ECM remodelling occur in vascular disorders, including aortic aneurysm (35), atherosclerosis (36), and VVs (2, 5-10).”
BackgroundInfluentialCysteine Protease Cathepsins in Atherosclerosis-Based Vascular Disease and Its Complications
Cheng, X. W., Huang, Z., Kuzuya, M., Okumura, K., & Murohara, T. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.180935 · Cited by 138 · cited 12×
“In AAA and atherosclerosis lesions, various inflam- matory cells, including monocytes/macrophages, T cells, and MCs, participate in vascular ECM remodelling by releasing inflammatory cytokines to regulate vascular cell cathepsin expression or by directly releasing cathepsins (11, 18, 24).”
BackgroundInfluentialAnalysis of the connective tissue matrix and proteolytic activity of primary varicose veins
Gandhi, R. H., Irizarry, E., Nackman, G. B., Halpern, V. J., Mulcare, R. J., & Tilson, M. D. (1993) · Journal of Vascular Surgery · doi:10.1016/0741-5214(93)90336-k · Cited by 131 · cited 1×
“The pathological process involves extracellular matrix (ECM) remodelling and extensive proteolytic events (3, 4), which may be important in VV development — though direct evidence is still missing.”
BackgroundKitamoto, S., Sukhova, G. K., Sun, J., Yang, M., Libby, P., Love, V., Duramad, P., Sun, C., Zhang, Y., Yang, X., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.688523 · Cited by 130 · cited 6×
“Macrophages (18), T cells (17), and MCs (45) produce cathepsins in diseased arterial lesions.”
BackgroundSelf-citationPlatt, M. O., Ankeny, R. F., Shi, G.-P., Weiss, D., Vega, J. D., Taylor, W. R., & Jo, H. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00954.2006 · Cited by 114 · cited 3×
“level is greatly reduced or even deficient (18-21).”
BackgroundSelf-citationQin, Y., Cao, X., Guo, J., Zhang, Y., Pan, L., Zhang, H., Li, H., Tang, C., Du, J., & Shi, G. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs263 · Cited by 112 · cited 2×
“Cathepsin activities in elastin and collagen degradation (16, 17, 42-44), SMC apoptosis (42, 44) and migration (17), angiogenesis (42, 43), macrophage and T-cell transendothelium migration (16, 17, 42, 43), and T-cell proliferation (42-44) from aortic walls may also apply to venous walls - a hypothesis that was not te…”
BackgroundSelf-citationSansilvestri, P., Rupin, A., Jaisson, S., Fabiani, J., Verbeuren, T. J., & Vanhoutte, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000022846.22923.46 · Cited by 108 · cited 4×
“Studies of venous diseases, however, have been limited to increased expression of MMPs along with their endogenous inhibitors, TIMPs (4-10).”
BackgroundInfluentialBiochemical Assay of Collagen and Elastin in the Normal and Varicose Vein Wall
Venturi, M., Bonavina, L., Annoni, F., Colombo, L., Butera, C., Peracchia, A., & Mussini, E. (1996) · Journal of Surgical Research · doi:10.1006/jsre.1996.0038 · Cited by 106 · cited 1×
“During the development of VVs, the elastic network is damaged and deregulated, showing reduced and fragmented elastin along with disordered collagen distribution (37, 38).”
BackgroundMorphologic characteristics of varicose veins: possible role of metalloproteinases
Woodside, K. J., Hu, M., Burke, A. S., Murakami, M., Pounds, L. L., Killewich, L. A., Daller, J. A., & Hunter, G. C. (2003) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(03)00134-4 · Cited by 102 · cited 5×
“Studies of venous diseases, however, have been limited to increased expression of MMPs along with their endogenous inhibitors, TIMPs (4-10).”
BackgroundInfluentialRole of saphenous vein wall in the pathogenesis of primary varicose veins
Elsharawy, M., Naim, M. M., Abdel-Maguid, E. M., & Al-Mulhim, A. A. (2006) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2006.136937 · Cited by 101 · cited 2×
“These vascular cells are hypertrophic and proliferative in VV media (55), where they express MMPs to assist SMC rearrangement and migration from the media to the intima (38).”
BackgroundCheng, X. W., Obata, K., Kuzuya, M., Izawa, H., Nakamura, K., Asai, E., Nagasaka, T., Saka, M., Kimata, T., Noda, A., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000242331.99369.2f · Cited by 101 · cited 2×
“For example, Cyst C expression is reduced in atheroma (21), abdominal aortic aneurysms (21) and VVs (▶ Figure 3), but its expression remains almost unchanged in balloon-injured carotid arteries (40) and in myocardium of hypertensive heart failure (41).”
BackgroundResultSelf-citationCathepsin K Deficiency Reduces Elastase Perfusion–Induced Abdominal Aortic Aneurysms in Mice
Sun, J., Sukhova, G. K., Zhang, J., Chen, H., Sjöberg, S., Libby, P., Xia, M., Xiong, N., Gelb, B. D., & Shi, G. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.235002 · Cited by 100 · cited 2×
“Cathepsin activities in elastin and collagen degradation (16, 17, 42-44), SMC apoptosis (42, 44) and migration (17), angiogenesis (42, 43), macrophage and T-cell transendothelium migration (16, 17, 42, 43), and T-cell proliferation (42-44) from aortic walls may also apply to venous walls - a hypothesis that was not te…”
BackgroundSelf-citationCheng, X. W., Kuzuya, M., Sasaki, T., Arakawa, K., Kanda, S., Sumi, D., Koike, T., Maeda, K., Tamaya-Mori, N., Shi, G., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63114-8 · Cited by 92 · cited 2×
“For example, Cyst C expression is reduced in atheroma (21), abdominal aortic aneurysms (21) and VVs (▶ Figure 3), but its expression remains almost unchanged in balloon-injured carotid arteries (40) and in myocardium of hypertensive heart failure (41).”
BackgroundResultSelf-citationMast Cell Tryptase Deficiency Attenuates Mouse Abdominal Aortic Aneurysm Formation
Zhang, J., Sun, J., Lindholt, J. S., Sukhova, G. K., Sinnamon, M., Stevens, R. L., Adachi, R., Libby, P., Thompson, R. W., & Shi, G.-P. (2011) · Circulation Research · doi:10.1161/circresaha.111.243758 · Cited by 92 · cited 2×
“As MC-specific serine proteases, chymase and tryptase both contribute critically to AAAs, but each has its own unique mechanisms.”
BackgroundSelf-citationLibby, P., & Lee, R. T. (2000) · Circulation · doi:10.1161/01.cir.102.16.1874 · Cited by 90
Sansilvestri, P., Fioretti, F., Rupin, A., Senni, K., Fabiani, J. N., Godeau, G., & Verbeuren, T. J. (2007) · Clinical Science · doi:10.1042/cs20060170 · Cited by 87 · cited 4×
“Normal vascular tissues possess strictly regulated ECM components, whereas focal tissue damage and ECM remodelling occur in vascular disorders, including aortic aneurysm (35), atherosclerosis (36), and VVs (2, 5-10).”
BackgroundInfluentialCurrent Advances in the Pathogenesis of Varicose Veins
Naoum, J. J., Hunter, G. C., Woodside, K. J., & Chen, C. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2006.08.007 · Cited by 86 · cited 1×
“These vascular cells are hypertrophic and proliferative in VV media (55), where they express MMPs to assist SMC rearrangement and migration from the media to the intima (38).”
BackgroundCathepsin L Activity Is Essential to Elastase Perfusion–Induced Abdominal Aortic Aneurysms in Mice
Sun, J., Sukhova, G. K., Zhang, J., Chen, H., Sjöberg, S., Libby, P., Xiang, M., Wang, J., Peters, C., Reinheckel, T., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.230201 · Cited by 81 · cited 2×
“Cathepsin activities in elastin and collagen degradation (16, 17, 42-44), SMC apoptosis (42, 44) and migration (17), angiogenesis (42, 43), macrophage and T-cell transendothelium migration (16, 17, 42, 43), and T-cell proliferation (42-44) from aortic walls may also apply to venous walls - a hypothesis that was not te…”
BackgroundSelf-citationSansilvestri, P., Rupin, A., Jullien, N. D., Lembrez, N., Mestries, P., Fabiani, J. N., & Verbeuren, T. J. (2005) · Journal of Vascular Research · doi:10.1159/000087314 · Cited by 79
Matrix Metalloproteinases in Venous Tissue Remodeling and Varicose Vein Formation
Raffetto, J. D., & Khalil, R. A. (2008) · Current Vascular Pharmacology · doi:10.2174/157016108784911957 · Cited by 77 · cited 5×
“Therefore, although a counterbalance between MMPs and TIMPs may affect vein structural integrity (5), other families of proteolytic enzymes may also participate in VV development.”
BackgroundInfluentialImmunocytochemical Characterisation of the Inflammatory Cell Infiltrate of Varicose Veins
Sayer, G. L., & Smith, P. C. (2004) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2004.07.023 · Cited by 73 · cited 4×
“Studies have found that MCs infiltrate into VVs (26), where they release tryptases and chymases and other inflammatory mediators to participate in the pathological process on the VV wall (46, 47).”
BackgroundInfluentialMast Cells as Mediators and Modulators of Atherogenesis
Libby, P., & Shi, G. (2007) · Circulation · doi:10.1161/circulationaha.107.698480 · Cited by 71 · cited 4×
“In AAA and atherosclerosis lesions, various inflammatory cells, including monocytes/macrophages, T cells, and MCs, participate in vascular ECM remodelling by releasing inflammatory cytokines to regulate vascular cell cathepsin expression or by directly releasing cathepsins (11, 18, 24).”
BackgroundSelf-citationHalloran, B. G., & Baxter, B. T. (1995) · PubMed · Cited by 67
Qin, Y., & Shi, G. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.04.010 · Cited by 60
Self-citationMatrix metalloproteinases in the vein wall.
Kowalewski, R., Sobolewski, K., Wolańska, M., & Gacko, M. (2004) · PubMed · Cited by 59
Altered Processing of Fibronectin in Mice Lacking Heparin
Tchougounova, E., Forsberg, E., Angelborg, G., Kjellén, L., & Pejler, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008434200 · Cited by 56 · cited 1×
“Several studies have demonstrated that MCs and their specific proteases, tryptases and chymases, activate cathepsins (24, 45) and MMPs (48); convert angiotensin-I to angiotensin-II (24); degrade ECM fibronectin (49, 50); and induce SMC detachment and apoptosis (49).”
BackgroundTGF-β1 Upregulation in the Aging Varicose Vein
Pascual, G., Mendieta, C., García‐Honduvilla, N., Corrales, C., Bellón, J. M., & Buján, J. (2007) · Journal of Vascular Research · doi:10.1159/000100375 · Cited by 54
Huttunen, M., & Harvima, I. T. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06428.x · Cited by 51 · cited 1×
“Studies have found that MCs infiltrate into VVs (26), where they release tryptases and chymases and other inflammatory mediators to participate in the pathological process on the VV wall (46, 47).”
BackgroundCollagen alteration in vascular remodeling by hemodynamic factors
Ishikawa, Y., Asuwa, N., Ishii, T., Ito, K., Akasaka, Y., MASUDA, T., Zhang, L., & Kiguchi, H. (2000) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280000200 · Cited by 50 · cited 6×
“Studies of venous diseases, however, have been limited to increased expression of MMPs along with their endogenous inhibitors, TIMPs (4-10).”
BackgroundInfluentialLeukocyte involvement in the signs and symptoms of chronic venous disease. Perspectives for therapy.
Boisseau, M. (2007) · PubMed · Cited by 40
Pathogenic mechanisms in varicose vein disease: the role of hypoxia and inflammation
Ghaderian, S. M. H., Lindsey, N. J., Graham, A. M., Homer‐Vanniasinkam, S., & Akbarzadeh, R. (2010) · Pathology · doi:10.3109/00313025.2010.493865 · Cited by 35 · cited 1×
“(29), we detected no significant difference in CD31-positive capillary vessel area in the adventitia between NVs and VVs (▶ Figure 6 A).”
BackgroundTHE THEORETICAL BASIS OF VARICOSE VEIN FORMATION
ALEXANDER, C. J. (1972) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1972.tb50912.x · Cited by 30 · cited 1×
“But several observations challenged this theory: Normal valves appear frequently in varicose segments (32), valvular incompetence is often followed by dilation (32), and venous dilatation occurs usually in the distal but not at the proximal to the valve (33).”
BackgroundMichiels, C., Arnould, T., Janssens, D., Bajou, K., Geron, I., & Remacle, J. (1996) · PubMed · Cited by 24
Inhibitory Effect of TIMP Influences the Morphology of Varicose Veins
Aravind, B., Saunders, B., Navin, T. J., Sandison, A., Monaco, C. G., Paleolog, E. M., & Davies, A. H. (2010) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2010.04.028 · Cited by 22 · cited 16×
“Studies of venous diseases, however, have been limited to increased expression of MMPs along with their endogenous inhibitors, TIMPs (4-10).”
BackgroundMethodInfluential
Cited by
Vascular wall extracellular matrix proteins and vascular diseases
Xu, J., & Shi, G.-P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.07.008 · Cited by 381
Self-citationInvolvement of cystatin C in immunity and apoptosis
Zi, M., & Xu, Y. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.01.006 · Cited by 170
“However, recent studies increasingly reported direct involvement of cystatin C in many immunological disorders other than renal diseases, and cystatin C encoding gene can be subject to the regulation of cytokines under inflammatory or infectious conditions [15,16].”
BackgroundCystatin C is a disease‐associated protein subject to multiple regulation
Xu, Y., Ding, Y., Li, X., & Wu, X. (2015) · Immunology & Cell Biology · doi:10.1038/icb.2014.121 · Cited by 111
“14, 15 Thus, the oscillation of blood Cst C levels could actually reflect the change of Cst C production, consumption, inactivation or fibrillation (mentioned later) rather than its filtration in the kidney, and the readout of plasma Cst C concentration might have different clinical implications.”
BackgroundBarallobre‐Barreiro, J., Öklü, R., Lynch, M., Fava, M., Baig, F., Yin, X., Barwari, T., Potier, D. N., Albadawi, H., Jahangiri, M., et al. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw075 · Cited by 69
“For example, increased levels of cathepsins have been observed in VSV.(39)”
BackgroundDilating venous disease: Pathophysiology and a systematic aspect to different vascular territories
Yetkın, E., & İleri, M. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.04.016 · Cited by 47
Metadata
- Authors
- Xu, N., Zhang, Y.-Y., Lin, Y., Bao, B., Zheng, L., Shi, G.-P., & Liu, J.
- Affiliations
- Hefei University of Technology (CN)
- Brigham and Women's Hospital (US)
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2014
- Volume
- 112
- Issue
- 02
- Pages
- 333-344
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2027617961
- Cited by
- 15
- References
- 56
- Citations by year
- 2025: 3 · 2023: 1 · 2021: 1 · 2020: 3 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 2
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thrombosis and Haemostasis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation (Grant No. 31171315, to J.L.)
- Topics
- Health Sciences › Medicine › Surgery › Diagnosis and Treatment of Venous Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- varicose veins, cathepsin L, cathepsin K, cathepsin B, cathepsin S, cystatin C, chronic venous disease, extracellular matrix remodeling, matrix degradation, inflammation, mast cells, T cells, macrophages, great saphenous vein, endothelial cells, smooth muscle cells
- MeSH terms
- Adult, Cathepsins, Female, Humans, Immunohistochemistry, Inflammation, Male, Mast Cells, Middle Aged, Muscle, Smooth, Vascular, Saphenous Vein, T-Lymphocytes, Varicose Veins, Biomarkers, Up-Regulation, Case-Control Studies, Myocytes, Smooth Muscle, Endothelial Cells, Cystatin C
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.